Page 130 - Read Online
P. 130

Page 8 of 8                                                  Ding et al. Hepatoma Res 2019;5:10  I  http://dx.doi.org/10.20517/2394-5079.2018.115


                   plasma and is associated with a response to pegylated interferon Alfa-2a and uucleos(t)ide analogues. J Infect Dis 2016;213:224-32.
               29.  van Bommel F, Bartens A, Mysickova A, Hofmann J, Kruger DH, et al. Serum hepatitis B virus RNA levels as an early predictor of
                   hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors. Hepatology 2015;61:66-76.
               30.  van Bommel F, van Bommel A, Krauel A, Wat C, Pavlovic V, et al. Serum HBV RNA as a predictor of peginterferon Alfa-2a (40KD)
                   response in patients with HBeAg-positive chronic hepatitis B. J Infect Dis 2018;218:1066-74.
               31.  Huang YW, Takahashi S, Tsuge M, Chen CL, Wang TC, et al. On-treatment low serum HBV RNA level predicts initial virological
                   response in chronic hepatitis B patients receiving nucleoside analogue therapy. Antivir Ther 2015;20:369-75.
               32.  Wang J, Du M, Huang H, Chen R, Niu J, et al. Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”: Consistent
                   loss of serum HBV RNA might predict the “para-functional cure” of chronic hepatitis B. J Hepatol 2017;66:462-3.
               33.  Tsuge M, Murakami E, Imamura M, Abe H, Miki D, et al. Serum HBV RNA and HBeAg are useful markers for the safe
                   discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. J Gastroenterol 2013;48:1188-204.
               34.  Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells
                   do not originate from replicating virus. Hepatology 1996;23:405-13.
               35.  Su Q, Wang SF, Chang TE, Breitkreutz R, Hennig H, et al. Circulating hepatitis B virus nucleic acids in chronic infection :
                   representation of differently polyadenylated viral transcripts during progression to nonreplicative stages. Clin Cancer Res
                   2001;7:2005-15.
               36.  Hacker HJ, Zhang W, Tokus M, Bock T, Schroder CH. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine
                   therapy. Ann N Y Acad Sci 2004;1022:271-81.
               37.  Kairat A, Beerheide W, Zhou G, Tang ZY, Edler L, et al. Truncated hepatitis B virus RNA in human hepatocellular carcinoma: its
                   representation in patients with advancing age. Intervirology 1999;42:228-37.
   125   126   127   128   129   130   131   132   133   134   135